Inotodiol induces hepatocellular carcinoma apoptosis by activation of MAPK/ERK pathway.
Hepatocellular carcinoma(HCC) has a high mortality and morbidity rate and seriously jeopardizes human life. Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. There...
Saved in:
| Main Authors: | Yushuang Xing, Di Jia, Xinping Zhu, Jialu Yang, Zhipeng Gao, Nana Meng, Haohao Xu, Mengxiao Wang, Shijun Chang, Mingqian Zhao, Shanbo Zhang, Zichen Mu, Qiang Tang, Weiming Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0318450 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PGRP-S promotes hepatocellular carcinoma progression via MAPK/ERK pathway by interaction with TTC1
by: Huifang Zhu, et al.
Published: (2025-08-01) -
L-741626 inhibits hepatocellular carcinoma progression by targeting Ref-1 to suppress MAPK/ERK signalling pathway activity
by: Shuiling Jin, et al.
Published: (2025-04-01) -
EIF3B affects the invasion and metastasis of hepatocellular carcinoma cells via the TGFBI/MAPK/ERK pathway
by: Ling Wang, et al.
Published: (2025-01-01) -
Peptide CCAT1-70aa promotes hepatocellular carcinoma proliferation and invasion via the MAPK/ERK pathway
by: Wu Xianjian, et al.
Published: (2025-08-01) -
Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
by: Taryn E Gillies, et al.
Published: (2020-10-01)